vs
STEM, INC.（STEM）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
STEM, INC.的季度营收约是UNIVERSAL HEALTH REALTY INCOME TRUST的1.9倍（$47.1M vs $24.5M），UNIVERSAL HEALTH REALTY INCOME TRUST净利率更高（17.7% vs -33.9%，领先51.6%），UNIVERSAL HEALTH REALTY INCOME TRUST同比增速更快（-0.7% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs -1.3%）
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
STEM vs UHT — 直观对比
营收规模更大
STEM
是对方的1.9倍
$24.5M
营收增速更快
UHT
高出14.9%
-15.6%
净利率更高
UHT
高出51.6%
-33.9%
两年增速更快
STEM
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.1M | $24.5M |
| 净利润 | $-16.0M | $4.3M |
| 毛利率 | 48.9% | — |
| 营业利润率 | -17.7% | 34.7% |
| 净利率 | -33.9% | 17.7% |
| 营收同比 | -15.6% | -0.7% |
| 净利润同比 | 68.8% | -7.2% |
| 每股收益（稀释后） | $-4.40 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STEMUHT
| Q4 25 | $47.1M | $24.5M | ||
| Q3 25 | $38.2M | $25.3M | ||
| Q2 25 | $38.4M | $24.9M | ||
| Q1 25 | $32.5M | $24.5M | ||
| Q4 24 | $55.8M | $24.6M | ||
| Q3 24 | $29.3M | $24.5M | ||
| Q2 24 | $34.0M | $24.7M | ||
| Q1 24 | $25.5M | $25.1M |
净利润STEMUHT
| Q4 25 | $-16.0M | $4.3M | ||
| Q3 25 | $-23.8M | $4.0M | ||
| Q2 25 | $202.5M | $4.5M | ||
| Q1 25 | $-25.0M | $4.8M | ||
| Q4 24 | $-51.1M | $4.7M | ||
| Q3 24 | $-148.3M | $4.0M | ||
| Q2 24 | $-582.3M | $5.3M | ||
| Q1 24 | $-72.3M | $5.3M |
毛利率STEMUHT
| Q4 25 | 48.9% | — | ||
| Q3 25 | 35.5% | — | ||
| Q2 25 | 33.4% | — | ||
| Q1 25 | 32.4% | — | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 27.6% | — | ||
| Q1 24 | -95.0% | — |
营业利润率STEMUHT
| Q4 25 | -17.7% | 34.7% | ||
| Q3 25 | -33.6% | 33.2% | ||
| Q2 25 | -34.8% | 35.6% | ||
| Q1 25 | -65.0% | 36.8% | ||
| Q4 24 | -84.4% | 37.6% | ||
| Q3 24 | -493.2% | 34.7% | ||
| Q2 24 | -1705.5% | 38.7% | ||
| Q1 24 | -267.0% | 37.6% |
净利率STEMUHT
| Q4 25 | -33.9% | 17.7% | ||
| Q3 25 | -62.2% | 15.9% | ||
| Q2 25 | 527.8% | 18.1% | ||
| Q1 25 | -76.9% | 19.5% | ||
| Q4 24 | -91.6% | 18.9% | ||
| Q3 24 | -506.3% | 16.3% | ||
| Q2 24 | -1712.6% | 21.3% | ||
| Q1 24 | -283.9% | 21.1% |
每股收益（稀释后）STEMUHT
| Q4 25 | $-4.40 | $0.32 | ||
| Q3 25 | $-2.84 | $0.29 | ||
| Q2 25 | $-1.79 | $0.32 | ||
| Q1 25 | $-0.15 | $0.34 | ||
| Q4 24 | $-15.29 | $0.34 | ||
| Q3 24 | $-18.24 | $0.29 | ||
| Q2 24 | $-71.81 | $0.38 | ||
| Q1 24 | $-0.46 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $48.9M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | $-249.4M | $152.4M |
| 总资产 | $308.9M | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资STEMUHT
| Q4 25 | $48.9M | $6.7M | ||
| Q3 25 | $43.1M | $6.9M | ||
| Q2 25 | $40.8M | $6.6M | ||
| Q1 25 | $58.6M | $7.0M | ||
| Q4 24 | $56.3M | $7.1M | ||
| Q3 24 | $75.4M | $6.4M | ||
| Q2 24 | $89.6M | $5.6M | ||
| Q1 24 | $112.8M | $7.7M |
总债务STEMUHT
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益STEMUHT
| Q4 25 | $-249.4M | $152.4M | ||
| Q3 25 | $-235.7M | $158.6M | ||
| Q2 25 | $-214.1M | $165.2M | ||
| Q1 25 | $-417.5M | $172.2M | ||
| Q4 24 | $-398.4M | $179.5M | ||
| Q3 24 | $-344.1M | $181.6M | ||
| Q2 24 | $-203.2M | $190.7M | ||
| Q1 24 | $371.6M | $196.5M |
总资产STEMUHT
| Q4 25 | $308.9M | $564.9M | ||
| Q3 25 | $362.6M | $568.0M | ||
| Q2 25 | $379.2M | $573.0M | ||
| Q1 25 | $405.1M | $573.5M | ||
| Q4 24 | $437.4M | $580.9M | ||
| Q3 24 | $537.8M | $584.3M | ||
| Q2 24 | $691.5M | $586.6M | ||
| Q1 24 | $1.3B | $596.2M |
负债/权益比STEMUHT
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $49.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流STEMUHT
| Q4 25 | $8.2M | $49.1M | ||
| Q3 25 | $11.4M | $10.2M | ||
| Q2 25 | $-21.3M | $13.7M | ||
| Q1 25 | $8.5M | $11.6M | ||
| Q4 24 | $-14.7M | $46.9M | ||
| Q3 24 | $-9.4M | $9.9M | ||
| Q2 24 | $-11.9M | $12.1M | ||
| Q1 24 | $-621.0K | $11.7M |
现金转化率STEMUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | -0.11× | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STEM
暂无分部数据
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
